CollPlant Biotechnologies Ltd Cash and Restricted Cash
CollPlant Biotechnologies Ltd (CLGN) had Cash and Restricted Cash of $5.59 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-26
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.59M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.43M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.91M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.92M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $5.59M 20-F · filed 2026-03-26 |
| 2025-06-30 | $11.43M 6-K · filed 2025-08-20 |
| 2024-12-31 | $11.91M 20-F · filed 2026-03-26 |
| 2024-06-30 | $18.92M 6-K · filed 2025-08-20 |
| 2023-12-31 | $26.67M 20-F · filed 2026-03-26 |
| 2023-06-30 | $22.37M 6-K · filed 2024-08-20 |
| 2022-12-31 | $29.86M 20-F · filed 2026-03-26 |
| 2022-06-30 | $36.50M 6-K · filed 2022-08-25 |
| 2021-12-31 | $13.37M 20-F · filed 2025-03-26 |
| 2021-06-30 | $17.68M 6-K · filed 2022-08-25 |
| 2020-12-31 | $3.53M 20-F · filed 2024-04-04 |
| 2020-06-30 | $3.85M 6-K · filed 2021-08-19 |
| 2019-12-31 | $3.97M 20-F · filed 2022-03-24 |
| 2019-06-30 | $1.91M 6-K · filed 2020-08-28 |
| 2018-12-31 | $5.66M 20-F · filed 2022-03-24 |
| 2017-12-31 | $5.28M 20-F · filed 2021-03-26 |